SkepSkep
All episodes
Unhedged — Novo Nordisk, Eli Lilly and the GLP-1 economy
Buzzing ratingBUZZING· 70%20m·2024-10-10·Money

Novo Nordisk, Eli Lilly and the GLP-1 economy

Unhedged

Eli Lilly’s shares have surged 750 per cent over five years. Novo Nordisk’s are up about 360 per cent in the same period. It's been an awesome run for these companies. But how much longer can it last? Today on the show, Rob Armstrong and Aiden Reiter talk to the FT’s US pharmaceutical and biotech correspondent Oliver…

Listen now
Buzzmeter · cross-platform
Buzzing rating
70%
BUZZING

Active swarm energy. Strong reception, real community buzz.

Hive Vote · Skep listeners
New on SkepAwaiting the hive's first votes

Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.

Rate this episode

Add your vote to the Hive — listeners rate every episode after they finish.

Rate this episode
Recent reviews
  • No reviews yet — be the first.

One great episode in your inbox, daily — free.

One email a day, unsubscribe anytime. No spam, ever.